Latest Breaking News On - Dean for clinical translational research - Page 1 : comparemela.com

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114
clevelandstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clevelandstar.com Daily Mail and Mail on Sunday newspapers.

United statesRobertb steinProtagenic therapeutics incDepartment of psychiatry at massachusettsExchange commissionDean for clinical translational researchProtagenic therapeuticsTrial focusTreatment resistant depressionGeneralized anxietyAxiom real time metricsData analyticsMaurizio favaMassachusetts general hospitalAssociate deanTranslational research

Protagenic Therapeutics, Inc : Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Protagenic Therapeutics, Inc : Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesBaden wübergRobertb steinExchange commissionProtagenic therapeutics incDepartment of psychiatry at massachusettsProtagenic therapeutics inc viewDean for clinical translational researchProtagenic therapeuticsTrial focusTreatment resistant depressionGeneralized anxietyAxiom real time metricsData analyticsMaurizio favaMassachusetts general hospital

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobertb steinDepartment of psychiatry at massachusettsDean for clinical translational researchExchange commissionProtagenic therapeutics incProtagenic therapeuticsTrial focusTreatment resistant depressionGeneralized anxietyAxiom real time metricsData analyticsMaurizio favaMassachusetts general hospitalAssociate deanTranslational research

Axsome Therapeutics (AXSM) Announces FDA Approval of AUVELITY

Axsome Therapeutics (AXSM) Announces FDA Approval of AUVELITY
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichael pollockHerriot tabuteauDanv iosifescuAxsome therapeutics incClinical research divisionDrug administrationHarvard medical schoolDepartment of psychiatryNathan kline institute for psychiatric researchDean for clinical translational researchClinical trials network instituteBipolar support allianceYork university school of medicineN methyld aspartateMassachusetts general hospital

Axsome Therapeutics Announces Publication of Pivotal GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder in The Journal of Clinical Psychiatry

/PRNewswire/ Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central.

New yorkUnited statesHerriot tabuteauMark jacobsonPrnewswire axsome therapeutics incAxsome therapeutics incDrug administrationHarvard medical schoolDepartment of psychiatryDean for clinical translational researchClinical trials network instituteMajor depressive disorderClinical trialClinical psychiatryMaurizio favaMassachusetts general hospital